Skip to main content
Elsevier - PMC Mpox Collection logoLink to Elsevier - PMC Mpox Collection
. 2023 Feb 23;24(2):122–127. doi: 10.1016/j.vacun.2022.11.003

Knowledge and awareness of Algerian healthcare workers about human monkeypox and their attitude toward its vaccination: An online cross-sectional survey

Conocimiento y concienciación de los trabajadores sanitarios de Argelia acerca de la viruela del simio, y actitud de los mismos hacia la vacuna: encuesta transversal online.

Mohamed Lounis a,, Djihad Bencherit b, Samir Abdelhadi c
PMCID: PMC9946789  PMID: 36852211

Abstract

Objectives

This study was carried out to assess the level of knowledge of Algerian healthcare workers about human monkeypox, and their attitude toward its vaccination.

Methods

An online-based cross-sectional study using social media platforms targeting Algerian healthcare workers was conducted between 28 June and 18 September 2022.

Results

111 healthcare workers have answered the questionnaire. Overall, a medium level of knowledge (64.9%) was obtained with multiple gaps about the epidemiology and clinical features of this disease. Factors associated with high levels of knowledge included young age, being married and practicing outside the province town. Also, only 38.7% of the respondents were in favor of human monkeypox vaccination if recommended for free with COVID-19 vaccine uptake as a determinant factor of acceptance.

Conclusion

Results have shown a medium level of knowledge and a low rate of vaccination willingness. The findings of this study although not representative of all Algerian healthcare workers, could be a baseline for human monkeypox knowledge and vaccination in Algeria.

Keywords: Monkeypox, Knowledge, Attitude, vaccines, Algeria

Introduction

After the COVID-19 pandemic and its drastic consequences and sequelae, the world has been facing a new public health threat since May 6th 2022 as a result of the re-emergence of human monkeypox (HMPX) in different non endemic countries.1 The rapid spread of this disease has engendered a number of 66,551 cases. Prior to this, the WHO had declared the human monkeypox outbreak a public health emergency of international interest since July 2022.2 , 3

This disease is caused by monkeypox virus; a double-stranded DNA virus, one of the four Orthopoxvirus species pathogenic for humans with variola virus, cowpox virus, and vaccinia virus.4 , 5 The clinical picture of this disease shows suggestive small pox signs with an incubation period of 6 to 13 days (range from 5 to 21 days) and the formation of self-limiting lesions, skin nodules or disseminated rash that could be severe in some individuals, like children, pregnant women or immune-deficient persons. The case fatality rate of this disease varied from 3.6% to 10.6% in the endemic countries.1 , 5 Despite the name of monkeypox, the natural reservoir of this disease is still unknown.3 The virus is mainly transmitted from person to person close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.

Although HMPX has not been notified in Algeria, reported cases in some Arab countries including Bahrain, Egypt, Morocco, Qatar, Lebanon, Saudi Arabia, Sudan and United Arab Emirates3 puts the country at risk of its emergence which necessitates vigilant preparedness and response plans. In this way, healthcare workers (HCWs) are considered as a key group in any preventive measure to limit the spread of this disease.6 Thus, prompt assessment of their preparedness and their knowledge and awareness could be of great importance.7 This topic has been touched upon in many previous studies around the world.7, 8, 9, 10, 11, 12

Considering this context, the current study was conducted to evaluate the level of knowledge of Algerian healthcare workers about HMPX and their attitude toward HMPX vaccines.

Materials and methods

A cross-sectional Web-based survey was carried out in Algeria to evaluate knowledge and awareness of healthcare workers living and practicing in Algeria about human monkeypox and their attitude towards its vaccines, using self-administered questionnaire (SAQ). It was conducted between 28 June and 18 September 2022 by disseminating the Google Forms (Google LLC, Menlo Park, CA, USA, 2021) link on social media platforms in relation with the target population.

Participation in this study was voluntary and no financial incentives or compensations have been given. The participants’ identity was kept anonymous to control Hawthorne’s effect and information bias.

The SAQ was adopted from previous studies regarding attitude and knowledge about monkey pox in different countries10, 11, 12 and was administered in Arabic and French languages. It contains 22 multiple-choice items that were stratified into three sections: socio-demographic and professional characteristics (sex, age), knowledge level (using 23 knowledge items with yes/no responses) and attitude toward monkeypox vaccines. To estimate the knowledge level, each item was given a score of one for a correct response and a score of zero for an incorrect response. The scores of the 23 items were added up defining the final score that ranges from 0 to 23, with higher scores indicating better knowledge on HMPX. Finally, the mean level of was calculated (estimated at 14.9) and was used as a point cut-off to dichotomize the knowledge level as high or low as described previously.13

Statistical analysis

Data were analyzed using SPSS version 22.0 (SPSS Inc. Chicago, IL, USA, 2011). They were first presented as frequencies (n) and percentages (%) or mean ± SD for the score knowledge. Chi squared (χ2) and Ficher tests were used to assess the association between dependent and independent variables.

Subsequently, multinomial logistic regression was used to determine the suggested associated factors with HMPX knowledge an attitude toward HMPX vaccines. All statistical analyses have been performed with a confidence level (CI) of 95% and a significance level (Sig.) of ≤ 0.05.

Results

Overall, 111 healthcare workers have completed the questionnaire of this study. The general characteristics of the study population are shown in Table 1 . The population was dominated by females (70.3%), single individuals (60.4%), and those living in urban areas (91%) and aged between 18 and 30 years (61.3%).

Table 1.

General characteristics of the study population.

Variable Numbrer Frequency
Age 18–30 years old 68 61.3
31–40 years old 28 25.2
Overr 40 Years old 15 13.5
Sexe Female 78 70.3
Male 33 29.7
Marital Status Married 44 39.6
Single 67 60.4
Residence Rural 10 9.0
Urban 101 91.0
Occupation Physicians 45 40.5
Pharmacists 8 7.2
Paramedics 25 22.5
Veterinarians 3 2.7
Biologiste 2 1.8
Lab staff 2 1.8
Students 26 23.4
Professional experience Without 31 27.9
Less than 2 years 18 16.2
2–5 years 28 25.2
6–10 years 15 13.5
More than 10 years 19 17.1
Sector Private 13 11.7
Public 98 88.3
Working place Province 66 59.5
Daïra 25 22.5
Municipality 20 18.0
Attended regional conferences Yes 50 45.0
No 61 55.0
Attended national conferences Yes 36 32.4
No 75 67.6
Attended international conferences Yes 19 17.1
No 92 82.9
Influenza vaccine uptake Yes 37 33.3
No 74 66.7
COVID-19 vaccine uptake Yes 55 49.5
No 56 50.5

Regarding their professional status, physicians (40.5%) were the most represented category followed by students (23.4%) and paramedics (22.5%). The majority were practicing in the public sector (88.3%), generally in the province town (59.5%) and most of them were without any practice experience (27.9%) or with a professional experience of 2 to 5 years (25.2%). For their connection to scientific events, 45% of the respondents declared attending province level conference while, 32% and 17% declared that they attended national and international level conference respectively. In terms of their vaccination status, almost half (49.5%) of respondents were vaccinated against COVID-19 while one third (33.3%) only received influenza vaccine.

Human monkeypox knowledge

Results showed that 91.9 % of the respondents were aware of the current monkeypox pandemic while 61.3% had not heard of this disease before 2022.

Also, 46.7% of the respondents considered that this topic was normally treated by media, while 24.8% considered that it was overly publicized and the remaining portion (29.4%) saw the disease to be under-mediated. Consequently, 40% of the respondents declared being worried about the evolution of this disease while 36.2% said the opposite and 23.8% of them were indifferent.

Results showed that the mean level of knowledge was estimated at 64.9%. Furthermore, more than half (52.2%) of the knowledge items had a lower rate of correct responses than 70% and about three quarters (73.9%) had a lower rate than 80%. Additionally 34.2% didn’t know that there is vaccine (even not widely available) against monkeypox and almost a half (49.1%) knew that small pox vaccines are effective against monkeypox (Supplementary material).

Regarding the knowledge score, the mean score was estimated at 14.9 + 4.5 (of a maximum of 23). This score was used as a cut off for further analysis.

Factors associated with high levels of knowledge

Results of the univariate analysis showed that being a physician/pharmacist was significantly associated with high level of knowledge (Sig.<0.01) while paramedics were associated with the lower rates (Sig.<0.01). Additionally married individuals (Sig.=0.03) and those who attended regional (Sig.=0.03), national (Sig.=0.026) and international conferences (Sig.<0.01) had the highest level than their counterparts.

Results of the logistic regression showed however that, only younger individuals, married and those practicing out of the province were associated with the highest OR of high levels of knowledge (Table 2 ).

Table 2.

Factors associated with high level of knowledge about HMPX.

Variables High (%) Low (%) Sig. OR (CI 95 %) Sig.
Age 18–30 years old 40 (58.8) 28 (41.2) 0.244 183.404 (4.81–6993.117) 0.005
31–40 years old 21(75) 7 (25) 0.13 30.005 (1.819–494.833) 0.017
Over 40 years old 9 (60) 6 (40) 0.781* . .
Sexe Female 49 (62) 29 (38) 0.935 0.945 (0.285–3.129) 0.926
Male 21 (63) 12 (37) . .
Marital Status Married 33 (75) 11 (25) 0.0347 5.136 (1.19–22.162) 0.028
Single 37 (55.2) 30 (44.8) . .
Residence Rural 5 (50) 5 (50) 0.494* 0.353 (0.058–2.137) 0.257
Urban 65 (64.4) 36 (35.8) . .
Occupation Physician/pharmacist 43 (81.1) 10 (18.9) 0.0001 0.778 (0.053–11.531) 0.855
Paramedics 9 (36) 16 (64) 0.002* 0.057 (0.003–1.092) 0.057
Students 12 (46.2) 14 (55.8) 0.07 0.224 (0.011–4.668) 0.334
Others 6 (85.7) 1 (14.3) 0.257* . .
Professional experience Less than 2 years 11 (61.1) 7 (38.9) 1* 0.302 (0.047–1.926) 0.205
2–5 years 19 (67.9) 9 (32.1) 0.543 1.28 (0.224–7.315) 0.781
6–10 years 11 (73.3) 4 (26.7) 0.566* 2.73 (0.288–25.867) 0.381
More than 10 years 13 (68.4) 6 (31.2) 0.795* 11.801 (0.531–262.378) 0.119
Without 16 (51.6) 15 (48.4) 0.12 . .
Sector Private 12 (92.3) 1 (7.7) 0.029* 10.035 (0.379–265.897) 0.168
Public 58 (59.2) 40 (40.8) . . .
Working place Out of province 32 (71.1) 13 (28.9) 0.147 3.8 (1.075–13.43) 0.038
Province 38 (57.6) 28 (42.4) . .
Attended regional conferences Yes 37 (54) 13 (46) 0.03 2.31 (0.679–7.856) 0.18
No 33 (54.1) 28 (45.9) . .
Attended national conferences Yes 28 (77.8) 8 (22.2) 0.026 1.253 (0.339–4.628) 0.735
No 42 (56) 33 (44) .
Attended international conferences Yes 17 (89.5) 2 (10.5) 0.009* 5.232 (0.72–38.029) 0.102
No 53 (57.6) 39 (42.4) .

Data were analyzed using Chi-squared and Fisher (*) tests. Bold character indicates results with a significance difference (Sig.≤0.05).

Vaccination intention

Results showed that 38.7% among the asked healthcare workers were willing to be vaccinated if recommended in the near future. Factors associated with being in favour of vaccination included exclusively those who received COVID-19 vaccine (Sig.<0.01). This result was confirmed using multinomial logistic regression (OR = 5.484, Sig. = 0.001) (Table 3 ).

Table 3.

Factors associated with intention to get HMPX vaccine.

Variables Yes (%) No (%) Sig. OR (CI 95%) Sig.
Age 18–30 years 26 (38.2) 42 (61.8) 0.891 0.864 (0.061–12.225) 0.914
31–40 years 12 (42.9) 16 (57.1) 0.605 1.522 (0.208–11.12) 0.679
Over 40 years 5 (33.3) 10 (66.7) 0.779* . .
Sexe Female 27 (34.6) 51 (65.4) 0.170 0.786 (0.262–2.351) 0.666
Male 16 (48.5) 17 (51.5) . .
Marital Status Married 17 (38.6) 27 (61.4) 0.986 1.62 (0.479–5.478) 0.438
Single 26 (38.8) 41 (61.2) . .
Residence Rural 2 (20) 8 (80) 0.311* 0.283 (0.043–1.875) 0.191
Urban 41 (40.6) 60 (59.4) . .
Occupation Physician/Pharmacist 22 (41.5) 31 (58.5) 0.567 1.203 (0.147–9.821) 0.863
Paramedics 9 (36) 16 (64) 0.819* 1.221 (0.111–13.368) 0.87
Students 10 (38.5) 16 (61.5) 0.974 0.966 (0.083–11.201) 0.978
Others 2 (28.6) 5 (71.4) 0.704* . .
Professional experience Less than 2 years 12 (66.7) 6 (33.3) 0.015* 3.017 (0.553–16.455) 0.202
2–5 years 9 (32.1) 19 (67.9) 0.503* 0.577 (0.112–2.975) 0.511
6–10 years 5 (33.3) 10 (66.6) 0.779* 0.343 (0.038–3.11) 0.341
More than 10 years 6 (31.6) 13 (68.4) 0.608* 0.127 (0.009–1.701) 0.119
Without 11 (35.5) 20 (64.5) 0.661 . .
Sector Private 5 (38.5) 8 (61.5) 1* 0.54 (0.102–2.848) 0.468
Public 38(38.8) 60 (61.2) . .
Working place Out of prvince 18 (40) 27 (60) 0.822 0.802 (0.262–2.459) 0.7
Province 25 (37.9) 41 (62.1) . .
Attended regional conferences Yes 20 (40) 30 (60) 0.805 0.816 (0.254–2.616) 0.732
No 23 (37.7) 38 (62.3) . .
Attended national conferences Yes 17 (47.2) 19 (52.8) 0.204 1.834 (0.539–6.248) 0.332
No 26 (34.7) 49 (65.3) . .
Attended international conferences Yes 9 (47.4) 10 (52.6) 0.444* 1.487 (0.374–5.908) 0.573
No 34 (37) 58 (63) . .
Influenza vaccine uptake Yes 18 (48.6) 19 (52.4) 0.130 1.86 (0.642–5.389) 0.253
No 25 (33.8) 49 (66.2) . .
COVID-19 vaccine uptake Yes 31 (56.4) 24 (43.6) 0.000 5.484 (1.919–15.675) 0.001
No 12 (21.4) 44 (78.6) . .
Level of knowledge High 24 (34.3) 46 (65.7) 0.208 0.46 (0.139–1.527) 0.205
Low 19 (46.3) 22 (53.7) . .

Data were analyzed using Chi-squared and Fisher (*) tests. Bold character indicates results with a significance difference (Sig.≤ 0.05).

Discussion

The current study was conducted to evaluate the level of knowledge of Algerian healthcare workers about HMPX and their attitude toward its vaccination. To the best of our knowledge this is the first study reporting HMPX knowledge among healthcare workers in Algeria so far.

In fact, healthcare workers are a key group in combating health threats and especially following the emergence of new infectious agents.7 Thus, describing their level of knowledge and awareness especially in the initial steps is very helpful to estimate their preparedness to provide a proper response and sensitize the general population.

Overall, healthcare workers in this study have shown a medium level of knowledge (64.9% of correct responses). These results seemed to be unsatisfactory and the same observation was reported among different healthcare workers groups in different countries.7, 8, 9, 10, 11 , 14 Unsurprisingly, the level of knowledge reported in this study was higher when compared to those reported among the general population in Lebanon and in Saudi Arabia.14 , 15 These results make sense if one considers the lack of attention to this disease in non-endemic countries before the current outbreak.10 , 11

Regarding factors associated with higher levels of knowledge, results showed that younger individuals, married and those practicing out of the province town were associated with the highest score of knowledge. If the explanation of the two last parameters is unclear, the higher level of knowledge among younger individuals could be related to the fact that this category past most of its time in social media platforms and thus increasing their probability to face with subjects related to monkeypox increasing thus their curiosity.

In this study, only 37.8% of the asked healthcare workers were in favour of vaccination if recommended for free. This observation is not surprising knowing that a vaccine hesitancy is also common among this category.9 This rate is so far lower than the reported rates among healthcare workers in Italy (58.6%)9 and in Indonesia (96%).12 Additionally, a rate of 50.6% was reported among the general population in Saudi Arabia.16 The only factor of HMPX vaccines was COVID-19 vaccinated people. This could be explained that people who accepted COVID-19 vaccination are less subject to conspiracy theories regarding vaccines.

At last, this study is with limitations which could affect the generalizability of the results to all Algerian healthcare workers. In fact, the online based method of this survey could over-represent or under-represent certain categories and thus could affect directly the level of knowledge and the willingness to get the vaccine. This type of surveys over-represents mostly young healthcare workers who pass generally more time in social media platforms than aged ones and underestimate individuals without access to the internet. These selection biases are mainly due to the fact that the survey was conducted using social media platforms and was not supported or published by any official institution or websites. Another limitation of this study is related to the low number of respondents who answered to the questionnaire. Finally, in the absence of a validated questionnaire to the Algerian context, the questionnaire items were adopted from other languages which could add other biases to this study.

Conclusion

In conclusion this study, despite some limitations related the sample size and the sampling method, has shown some gaps of knowledge about human monkeypox among the studied healthcare workers in Algeria. The level of vaccine acceptance is also very low. Results of this study even they can not be generalized to all healthcare workers, could be used as a blossom for further studies to better understand this topic which could be helpful in the prevention against an eventual emergence of this disease in Algeria.

Human and animal rights

This study protocol was reviewed and approved by the Scientific Committee of the Faculty of natural and Life Sciences, University of Djelfa (Signed by the dean of the Faculty and the President of the Scientific Committee) with the reference number: 25/06/2022.

Informed consent and patient details

All participants provided their informed consent electronically prior to data collection. Participants who declined consent were not allowed to continue the study, and participants could withdraw from the survey at any time based on requirements of the Declaration of Helsinki Ethical principles.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.vacun.2022.11.003.

Appendix A. Supplementary data

Supplementary material

mmc1.xlsx (13.7KB, xlsx)

References

  • 1.World Health Organization Disease Outbreak News; Multi-country monkeypox outbreak in non-endemic countries. 21 May 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 Last accessed: 27 September. Available from.
  • 2.WHO, World Health Organization WHO Director-General’s Statement at the Press Conference Following IHR Emergency Committee Regarding the Multi-Country Outbreak of Monkeypox. https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergencycommittee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022 Last accessed: 25 September 2022. Available from.
  • 3.CDC Monkeypox, 2022 Global map & case count. 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html Last accessed: 27 September 2022. Available from.
  • 4.Sklenovská N., Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018;6:241. doi: 10.3389/fpubh.2018.00241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.CDC About Monkeypox. 2022. https://www.cdc.gov/poxvirus/monkeypox/treatment.html Last accessed: 27 September 2022. available from.
  • 6.Wilkason C., Lee C., Sauer L.M., Nuzzo J., McClelland A. Assessing and reducing risk to healthcare workers in outbreaks. Health Secur. 2020;18(3):205–211. doi: 10.1089/hs.2019.0131. [DOI] [PubMed] [Google Scholar]
  • 7.Sallam M., Al-Mahzoum K., Al-Tammemi A.B., Alkurtas M., Mirzaei F., Kareem N., et al. Assessing Healthcare workers’ knowledge and their confidence in the diagnosis and management of human Monkeypox: a cross-sectional study in a middle eastern country. Healthcare. 2022;10:1722. doi: 10.3390/healthcare10091722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Alsanafi M., Al-Mahzoum K., Sallam M. Monkeypox knowledge and confidence in diagnosis and management with evaluation of emerging virus infection conspiracies among health professionals in Kuwait. Pathogens. 2022;11:994. doi: 10.3390/pathogens11090994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Riccò M., Ferraro P., Camisa V., Satta E., Zaniboni A., Ranzieri S., et al. When a neglected tropical disease goes global: knowledge, attitudes and practices of italian physicians towards Monkeypox, preliminary results. Trop Med Infect Dis. 2022;7:135. doi: 10.3390/tropicalmed7070135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Harapan H., Setiawan A., Yufika A., Anwar S., Wahyuni S., Asrizal F., et al. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia. Pathog Glob Health. 2020;114(2):68–75. doi: 10.1080/20477724.2020.1743037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Harapan H., Setiawan A.M., Yufika A., Anwar S., Wahyuni S., Asrizal F.W., et al. Confidence in managing human monkeypox cases in Asia: a cross-sectional survey among general practitioners in Indonesia. Acta Trop. 2020;206 doi: 10.1016/j.actatropica.2020.105450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Harapan H., Wagner A.L., Yufika A., Setiawan A.M., Anwar S., Wahyuni S., et al. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: a cross-sectional study in Indonesia. Vaccine. 2020;38:6800–6806. doi: 10.1016/j.vaccine.2020.08.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alshahrani N.Z., Algethami M.R., Alarifi A.M., Alzahrani F., Sheerah H.A., Abdelaal A., et al. Knowledge and attitude regarding monkeypox virus among physicians in Saudi Arabia, a cross-sectional study. Researchsquare [Preprint] 2022 doi: 10.21203/rs.3.rs-1883068/v1. [cited 2022 July 22]; 20p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Youssef D., Abboud E., Kawthami M., Zheim Z., Abou Arrage N., Youssef J. When a neglected tropical zoonotic disease emerges in non-endemic countries: Need to proactively fill the unveiled knowledge gaps towards human monkeypox among the Lebanese population [Internet] Researchsquare [Preprint] 2022 doi: 10.21203/rs.3.rs-1998212/v1. [cited 2022 Aug 30]; 39p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Alshahrani N.Z., Alzahrani F., Alarifi A.M., Algethami M.R., Alhumam M.N., Ayied H.A.M., et al. Assessment of knowledge of Monkeypox viral infection among the general population in Saudi Arabia. Pathogens. 2022;11:904. doi: 10.3390/pathogens11080904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Temsah M.H., Aljamaan F., Alenezi S., Alhasan K., Saddik B., Al-Barag A., et al. Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: experience from Saudi Arabia. Travel Med Infect Dis. 2022;49 doi: 10.1016/j.tmaid.2022.102426. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.xlsx (13.7KB, xlsx)

Articles from Vacunas are provided here courtesy of Elsevier

RESOURCES